USPTO serial 79312543
ELIMSA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 7, 2023
- Examiner
- REID, CAILE MAUREEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ELIMSA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
NICOLE K. MCLAUGHLIN
Nicole K. McLaughlin DUANE MORRIS LLP30 South 17th StreetPhiladelphia, PA 19103-4196UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic and test kits, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic and test kits, namely, drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids for the presence of protein, DNA, RNA, antibody, nanobody, aptamer, peptide, and biopolymer; Diagnostic and test kits, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious diseases, oncology being cancers, neurological diseases, immunological diseases, cardiovascular diseases, genetic diseases, environmental diseases, dietary diseases, and pathogens; diagnostic reagents for medicinal use; medical diagnostic reagents; Kits for testing of body fluids, namely, medical diagnostic reagents and assays for testing body fluids, tissues or cells for microorganisms; Kits for testing of body fluids, namely, medical diagnostic reagents and assays for testing of body fluids and tissue of cells for human health, capture and detection reagents for environmental use, human health, agriculture, food and nutrition; laboratory and scientific equipment for detection, quantification of analytes, biopolymers or germs, and diagnosis of virus, disease and pathogens, namely, diagnostic media for bacteriological cultures, medical diagnostic test media in the form of strip, threads, multi-well plates, microbeads, nanobeads, for measuring pathological condition, phenotypic condition, genotypic condition; and replacement parts and fittings therefor | ACTIVE | — |
| 009 | Laboratory and scientific equipment for diagnostic testing and medical treatment, namely, test tubes, microscope slides, incubators, laboratory robots, and chromatography supports being chromatography apparatus for laboratory use; Laboratory and scientific equipment for diagnostic testing and medical treatment, namely, diagnostic apparatus for the detection of pathogens for laboratory or research use; Laboratory and scientific equipment for diagnostic testing and medical treatment, namely, medical diagnostic simulators for use as teaching aids for detecting pathogens, DNA analysis, and chromatography; electrophoresis laboratory apparatus and instruments for extracting biomolecules within enzyme-linked immunosorbent assays, immunoblots, polymerase chain reactions (PCR), hybridization, binding assays, nucleic acids, DNA, RNA, proteins, and antigens, not for medical purposes; analytical apparatus in the nature of an automated slide stainer for use in medical laboratories; and replacement parts and fittings therefor | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by YYZ Pharmatech, Inc.
- Other trademarks owned by YYZ Pharmatech, Inc.
- Other trademarks owned by YYZ Pharmatech, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Similar marks named ELIMSA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 18, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 3, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 12, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 12, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 7, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 7, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 7, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 21, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 20, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 20, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 30, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 30, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 30, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 27, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 15, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 14, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 14, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 14, 2022 | ALIE | ASSIGNED TO LIE | — |
| Nov 9, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 9, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 2, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 2, 2022 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Nov 2, 2022 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Nov 2, 2022 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| May 3, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 3, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 3, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 4, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 4, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 4, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 9, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 30, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 5, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 5, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 21, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 20, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 12, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 3, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |